<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Diagn Pathol</journal-id>
      <journal-title-group>
        <journal-title>Diagnostic Pathology</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1746-1596</issn>
      <publisher>
        <publisher-name>BioMed Central</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">21663603</article-id>
      <article-id pub-id-type="pmc">3123261</article-id>
      <article-id pub-id-type="publisher-id">1746-1596-6-51</article-id>
      <article-id pub-id-type="doi">10.1186/1746-1596-6-51</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Coexistence of early microinvasive endometrioid adenocarcinoma and CIN3 in the uterine cervix in a 32-year-old Japanese woman</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" corresp="yes" id="A1">
          <name>
            <surname>Terada</surname>
            <given-names>Tadashi</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <xref ref-type="aff" rid="I2">2</xref>
          <email>piyo0111jp@yahoo.co.jp</email>
        </contrib>
      </contrib-group>
      <aff id="I1"><label>1</label>Department of Pathology, Shizuoka City Shimizu Hospital, Shizuoka, Japan</aff>
      <aff id="I2"><label>2</label>Department of Pathology, Shizuoka City Shimizu Hospital, Miyakami 1231 Shimizu-Ku, Shizuoka 424-8636, Japan</aff>
      <pub-date pub-type="collection">
        <year>2011</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>10</day>
        <month>6</month>
        <year>2011</year>
      </pub-date>
      <volume>6</volume>
      <fpage>51</fpage>
      <lpage>51</lpage>
      <history>
        <date date-type="received">
          <day>9</day>
          <month>4</month>
          <year>2011</year>
        </date>
        <date date-type="accepted">
          <day>10</day>
          <month>6</month>
          <year>2011</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright &#xA9;2011 Terada; licensee BioMed Central Ltd.</copyright-statement>
        <copyright-year>2011</copyright-year>
        <copyright-holder>Terada; licensee BioMed Central Ltd.</copyright-holder>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0">
          <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0">http://creativecommons.org/licenses/by/2.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <self-uri xlink:href="http://www.diagnosticpathology.org/content/6/1/51"/>
      <abstract>
        <p>Simultaneous occurrence of early microinvasive endometrioid adenocarcinoma (EMEA) and CIN 3 in the uterine cervix is very rare in Japan. A 32-year-old Japanese woman was pointed out to have atypical cells in the cervical cytology. Colposcopic examination revealed irregular lesions in the cervix, and a biopsy showed simultaneous EMEA and CIN3. The EMEA was grade I and CIN3 corresponded to severe dysplasia/carcinoma in situ. Hysterectomy and lymph nodes dissection were performed. Grossly, mucosal irregularity and erosion were seen in the cervix. No tumor formation was recognized. The cervix was examined by serial sections. Microscopically, there were a tiny adenocarcinoma (0.5 cm in diameter and 0.3 cm in depth) and broad areas of CIN3. The adenocarcinoma was EMEA without mucins. The EMEA was FIGO stage 1A1. Immunohistochemically, the EMEA was positive for pancytokeratins (AE1/2 +++, CAM5.2 ++), cytokeratin (CK) 34&#x3B2;E12 +, CK5/6 +, CK7 +, CK18 +++, CK19 ++, CA19-9 +, CA125 +++, p53 +, ER +++, PgR +++, while it was negative for CK8, CK14, CK20, EMA, vimentin, CEA, desmin, smooth muscle actin, p63, chromogranin, synaptophysin, CD56, CD68, HER2/neu, MUC1, MUC2, MUC5AC, and MUC6. The CIN 3 was positive for pancytokeratins (AE1/2 +++, CAM5.2 +), cytokeratin (CK) 34&#x3B2;E12 +++, CK5/6 +++, CK7 +, EMA, CA19-9 +, CA125 +, p53 +, p63 +++, ER +++, and MUC1 +, while it was negative for CK8, CK14, CK18, CK19, CK20, vimentin, CEA, desmin, smooth muscle actin, chromogranin, synaptophysin, CD56, CD68, PgR, HER2/neu, MUC2, MUC5AC and MUC6. The lymph nodes showed no metastatic lesions (0/34). In conclusion, the author reported a rare case of simultaneous EMEA and CIN 3 with extensive immunohistochemical findings.</p>
      </abstract>
      <kwd-group>
        <kwd>early microinvasive adenocarcinoma</kwd>
        <kwd>CIN3</kwd>
        <kwd>uterine cervix</kwd>
        <kwd>histopathology</kwd>
        <kwd>immunohistochemistry</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec>
      <title>Introduction</title>
      <p>Malignant neoplasms of the uterine cervix are frequent in Japan. Most of them are squamous cell carcinoma and cervical intraepithelial neoplasm (CIN), and adenocarcinoma and its precursor lesions are rare in Japan.</p>
      <p>Adenocarcinoma of the uterine cervix was classified into adenocarcinoma NOS, mucinous adenocarcinoma, endometrioid adenocarcinoma, clear cell adenocarcinoma, serous adenocarcinoma mesonephric adenocarcinoma, early microinvasive adenocarcinoma, and adenocarcinoma in situ [<xref ref-type="bibr" rid="B1">1</xref>]. The mucinous adenocarcinoma was subclassified into endocervical, intestinal, signet-ring cell, minimal deviation, and villoglandular subtypes [<xref ref-type="bibr" rid="B1">1</xref>]. Glandular dysplasia equivalent to squamous dysplasia is also present.</p>
      <p>More than 90% of uterine tumorous lesions are squamous cell carcinoma and its precursor lesions. The precursor lesions of the squamous cell carcinoma had traditionally been called dysplasia (mild, moderate, and severe) and carcinoma in situ (CIS). Recently, they have been termed as cervical intraepithelial neoplasm (CIN) or squamous intraepithelial lesions (SIL) [<xref ref-type="bibr" rid="B1">1</xref>]. CIN is categorized as CIN 1-3, and SIL as low grade SIL (CIN 1) and high grade SIL(CIN2-3/CIS) (HGSIL) [<xref ref-type="bibr" rid="B1">1</xref>]. These lesions are known to be frequently associated with sexual intercourses and human papilloma virus (HPV) infection [<xref ref-type="bibr" rid="B1">1</xref>].</p>
      <p>According to WHO [<xref ref-type="bibr" rid="B1">1</xref>], adenocarcinoma is associated with CIN in about 40% of cases. However, Brown et al [<xref ref-type="bibr" rid="B2">2</xref>] reported that only 1 case of adenocarcinoma was found in 105 cases of CIN 3. Therefore, the coexistence of adenocarcinoma and CIN 3 is very rare. The author herein reports a case of simultaneous early microinvasive endometrioid adenocarcinomna (EMEC) and CIN 3 in a young Japanese woman.</p>
      <sec>
        <title>Case report</title>
        <p>A 32-year-old Japanese woman was found to have atypical cells in the cervical cytology at routine check. Colposcopic examination revealed irregular lesions in the cervix. A biopsy revealed simultaneous adenocarcinoma (Figure <xref ref-type="fig" rid="F1">1</xref>) and CIN3 (Figure <xref ref-type="fig" rid="F2">2</xref>). The adenocarcinoma have grade I atypia and CIN3 corresponded to severe dysplasia/carcinoma in situ.</p>
        <fig id="F1" position="float">
          <label>Figure 1</label>
          <caption>
            <p><bold>Biopsy of uterine cervix</bold>. The biopsy shows atypical glands with hyperchromatic nuclei and with structural atypia. This lesion is regarded as adenocarcinoma. HE, &#xD7;100.</p>
          </caption>
          <graphic xlink:href="1746-1596-6-51-1"/>
        </fig>
        <fig id="F2" position="float">
          <label>Figure 2</label>
          <caption>
            <p><bold>Biopsy of uterine cervix</bold>. The biopsy shows atypical squamous lesion. The atypical cells showed hyperchromatic nuclei and occupy all layers. The polarity and stratification are lost. The lesion was regarded as CIN3. HE, &#xD7;100.</p>
          </caption>
          <graphic xlink:href="1746-1596-6-51-2"/>
        </fig>
        <p>Hysterectomy and lymph nodes dissection were performed. Grossly, mucosal irregularity and erosion were seen in the cervix (Figure <xref ref-type="fig" rid="F3">3</xref>). No tumor formation was recognized. The cervix was examined by serial sections. There were a tiny adenocarcinoma (0.5 cm in diameter and 0.3 cm in depth) (Figure <xref ref-type="fig" rid="F4">4</xref>) and broad areas of CIN3 (Figure <xref ref-type="fig" rid="F5">5</xref>). Both lesions are separate, and no merges between both lesions were seen. The adenocarcinoma was EMEA without mucins, as revealed by negative alcian blue/PAS staining. The lymph nodes were negative for metastasis (0/34). No metastatic foci were found in the body. The EMEA was FIGO stage 1A1.</p>
        <fig id="F3" position="float">
          <label>Figure 3</label>
          <caption>
            <p><bold>Gross features of resected uterus</bold>. The cervix shows irregularity and erosions. No apparent tumor is seen.</p>
          </caption>
          <graphic xlink:href="1746-1596-6-51-3"/>
        </fig>
        <fig id="F4" position="float">
          <label>Figure 4</label>
          <caption>
            <p><bold>Microscopic features of the resected uterus</bold>. The adenocarcinoma component The adenocarcinoma is endometrioid adenocarcinoma. The carcinoma is small with mild invasion. HE &#xD7;50.</p>
          </caption>
          <graphic xlink:href="1746-1596-6-51-4"/>
        </fig>
        <fig id="F5" position="float">
          <label>Figure 5</label>
          <caption>
            <p><bold>Microscopic features of the resected uterus</bold>. The CIN3 component. CIN3 without invasion is seen. HE &#xD7;50.</p>
          </caption>
          <graphic xlink:href="1746-1596-6-51-5"/>
        </fig>
        <p>An immunohistochemical study was performed with the use of DAKO Envision method (Dako Corp., Glostrup, Denmark), as described previously [<xref ref-type="bibr" rid="B3">3</xref>-<xref ref-type="bibr" rid="B7">7</xref>]. The immunohistochemical results are shown in Table <xref ref-type="table" rid="T1">1</xref>. Immunohistochemically, the EMEA was positive for pancytokeratins (AE1/2 +++, CAM5.2 ++), cytokeratin (CK) 34&#x3B2;E12 +, CK5/6 +, CK7 +, CK18 +++(Figure <xref ref-type="fig" rid="F6">6</xref>), CK19 ++, CA19-9 +, CA125 +++ (Figure <xref ref-type="fig" rid="F7">7</xref>), p53 +, ER +++, PgR +++, while it was negative for CK8, CK14, CK20, EMA, vimentin, CEA, desmin, smooth muscle actin, p63, chromogranin, synaptophysin, CD56, CD68, HER2/neu, MUC1, MUC2, MUC5AC, and MUC6. The CIN 3 was positive for pancytokeratins (AE1/2 +++, CAM5.2 +), cytokeratin (CK) 34&#x3B2;E12 +++ (Figure <xref ref-type="fig" rid="F8">8</xref>), CK5/6 +++, CK7 +, EMA, CA19-9 +, CA125 +, p53 +, p63 +++ (Figure <xref ref-type="fig" rid="F9">9</xref>), ER +++, and MUC1 + (Figure <xref ref-type="fig" rid="F10">10</xref>), while it was negative for CK8, CK14, CK18, CK19, CK20, vimentin, CEA, desmin, smooth muscle actin, chromogranin, synaptophysin, CD56, CD68, PgR, HER2/neu, MUC2, MUC5AC, and MUC6. The patient is now free from tumor 4 months after the operation.</p>
        <table-wrap id="T1" position="float">
          <label>Table 1</label>
          <caption>
            <p>Immunohistochemical reagents and results</p>
          </caption>
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th/>
                <th/>
                <th/>
                <th align="left" colspan="2">Results</th>
              </tr>
              <tr>
                <th align="left">Antigens</th>
                <th align="left">Antibodies (clone)</th>
                <th align="left">Sources</th>
                <th align="left"><bold>EMEA</bold>.</th>
                <th align="left">CIN3</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td align="left">Pancytokeratin</td>
                <td align="left">AE1/3</td>
                <td align="left">Dako Corp. Glostrup, Denmark</td>
                <td align="left">+++</td>
                <td align="left">+++</td>
              </tr>
              <tr>
                <td align="left">Pancytokeratin</td>
                <td align="left">CAM5.2</td>
                <td align="left">Beckton-Dickinson, CA, USA</td>
                <td align="left">++</td>
                <td align="left">+</td>
              </tr>
              <tr>
                <td align="left">HMWCK</td>
                <td align="left">34&#x3B2;E12</td>
                <td align="left">Dako</td>
                <td align="left">+</td>
                <td align="left">+++</td>
              </tr>
              <tr>
                <td align="left">CK5/6</td>
                <td align="left">D5/16</td>
                <td align="left">Dako</td>
                <td align="left">+</td>
                <td align="left">+++</td>
              </tr>
              <tr>
                <td align="left">CK7</td>
                <td align="left">N1626</td>
                <td align="left">Dako</td>
                <td align="left">+</td>
                <td align="left">+</td>
              </tr>
              <tr>
                <td align="left">CK8</td>
                <td align="left">DC10</td>
                <td align="left">Dako</td>
                <td align="left">-</td>
                <td align="left">-</td>
              </tr>
              <tr>
                <td align="left">CK14</td>
                <td align="left">LL002</td>
                <td align="left">Novocastra, Newcastle upon type, UK</td>
                <td align="left">-</td>
                <td align="left">-</td>
              </tr>
              <tr>
                <td align="left">CK 18</td>
                <td align="left">DC10</td>
                <td align="left">Dako</td>
                <td align="left">+++</td>
                <td align="left">-</td>
              </tr>
              <tr>
                <td align="left">CK 19</td>
                <td align="left">RCK 108</td>
                <td align="left">Progen, Heidelberg, Germany</td>
                <td align="left">++</td>
                <td align="left">-</td>
              </tr>
              <tr>
                <td align="left">CK 20</td>
                <td align="left">K20.8</td>
                <td align="left">Dako</td>
                <td align="left">-</td>
                <td align="left">-</td>
              </tr>
              <tr>
                <td align="left">EMA</td>
                <td align="left">E29</td>
                <td align="left">Dako</td>
                <td align="left">-</td>
                <td align="left">+</td>
              </tr>
              <tr>
                <td align="left">Vimentin</td>
                <td align="left">Vim 3B4</td>
                <td align="left">Dako</td>
                <td align="left">-</td>
                <td align="left">-</td>
              </tr>
              <tr>
                <td align="left">CEA</td>
                <td align="left">polyclonal</td>
                <td align="left">Dako</td>
                <td align="left">-</td>
                <td align="left">-</td>
              </tr>
              <tr>
                <td align="left">CA19-9</td>
                <td align="left">NS19-9</td>
                <td align="left">TBF Lab, Tokyo Japan</td>
                <td align="left">+</td>
                <td align="left">+</td>
              </tr>
              <tr>
                <td align="left">CA125</td>
                <td align="left">NS125</td>
                <td align="left">TFB Lab</td>
                <td align="left">+++</td>
                <td align="left">+</td>
              </tr>
              <tr>
                <td align="left">Desmin</td>
                <td align="left">D33</td>
                <td align="left">Dako</td>
                <td align="left">-</td>
                <td align="left">-</td>
              </tr>
              <tr>
                <td align="left">ASMA</td>
                <td align="left">1A4</td>
                <td align="left">Dako</td>
                <td align="left">-</td>
                <td align="left">-</td>
              </tr>
              <tr>
                <td align="left">p53 protein</td>
                <td align="left">DO-7</td>
                <td align="left">Dako</td>
                <td align="left">+</td>
                <td align="left">+</td>
              </tr>
              <tr>
                <td align="left">p63</td>
                <td align="left">4A4</td>
                <td align="left">Dako</td>
                <td align="left">-</td>
                <td align="left">+++</td>
              </tr>
              <tr>
                <td align="left">Chromogranin</td>
                <td align="left">DAK-A3</td>
                <td align="left">Dako</td>
                <td align="left">-</td>
                <td align="left">-</td>
              </tr>
              <tr>
                <td align="left">Synaptophysin</td>
                <td align="left">Polyconal</td>
                <td align="left">Dako</td>
                <td align="left">-</td>
                <td align="left">-</td>
              </tr>
              <tr>
                <td align="left">CD56</td>
                <td align="left">UJ13A</td>
                <td align="left">Dako</td>
                <td align="left">-</td>
                <td align="left">-</td>
              </tr>
              <tr>
                <td align="left">CD68</td>
                <td align="left">KP-1</td>
                <td align="left">Dako</td>
                <td align="left">-</td>
                <td align="left">-</td>
              </tr>
              <tr>
                <td align="left">ER</td>
                <td align="left">M7047</td>
                <td align="left">Dako</td>
                <td align="left">+++</td>
                <td align="left">+++</td>
              </tr>
              <tr>
                <td align="left">PgR</td>
                <td align="left">1A6</td>
                <td align="left">Novocastra</td>
                <td align="left">+++</td>
                <td align="left">-</td>
              </tr>
              <tr>
                <td align="left">HER2/neu</td>
                <td align="left">CB11</td>
                <td align="left">Ventana Japan, Tokyo</td>
                <td align="left">-</td>
                <td align="left">-</td>
              </tr>
              <tr>
                <td align="left">MUC1</td>
                <td align="left">Ma695</td>
                <td align="left">Novocastra</td>
                <td align="left">-</td>
                <td align="left">+</td>
              </tr>
              <tr>
                <td align="left">MUC2</td>
                <td align="left">CCp58</td>
                <td align="left">Novocastra</td>
                <td align="left">-</td>
                <td align="left">-</td>
              </tr>
              <tr>
                <td align="left">MUC5AC</td>
                <td align="left">CLH2</td>
                <td align="left">Novocastra</td>
                <td align="left">-</td>
                <td align="left">-</td>
              </tr>
              <tr>
                <td align="left">MUC6</td>
                <td align="left">CLH5</td>
                <td align="left">Novocastra</td>
                <td align="left">-</td>
                <td align="left">-</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <p>+++, strongly positive. ++, moderately positive. +, mildly positive. -, negative. EMEA, early microinvasive endometrioid adenocarcinoma. CIN3, cervical intraepithelial neoplasm grade 3. HMWCK, high molecular weight cytokeratin. CK, cytokeratin. EMA, epithelial membrane antigen. CEA, carcinoembryonic antigen. CA19-9, carbohydrate antigen 19-9. CA125, carbohydrate antigen 125. ASMA, &#x3B1;-smooth muscle antigen. ER, estrogen receptor. PgR, progesterone receptor.</p>
          </table-wrap-foot>
        </table-wrap>
        <fig id="F6" position="float">
          <label>Figure 6</label>
          <caption>
            <p><bold>Immunohistochemical features</bold>. The adenocarcinoma component is strongly positive for cytokeratin 18. &#xD7;100.</p>
          </caption>
          <graphic xlink:href="1746-1596-6-51-6"/>
        </fig>
        <fig id="F7" position="float">
          <label>Figure 7</label>
          <caption>
            <p><bold>Immunohistochemical features</bold>. The adenocarcinoma component is strongly positive for CA125. &#xD7;100.</p>
          </caption>
          <graphic xlink:href="1746-1596-6-51-7"/>
        </fig>
        <fig id="F8" position="float">
          <label>Figure 8</label>
          <caption>
            <p><bold>Immunohistochemical features</bold>. The CIN3 component was strongly positive for cytokeratin 34&#x3B2;E12. &#xD7;100.</p>
          </caption>
          <graphic xlink:href="1746-1596-6-51-8"/>
        </fig>
        <fig id="F9" position="float">
          <label>Figure 9</label>
          <caption>
            <p><bold>Immunohistochemical features</bold>. The CIN3 component was strongly positive for p63. &#xD7;100.</p>
          </caption>
          <graphic xlink:href="1746-1596-6-51-9"/>
        </fig>
        <fig id="F10" position="float">
          <label>Figure 10</label>
          <caption>
            <p><bold>Immunohistochemical features</bold>. The CIN3 component was positive for MUC1. &#xD7;100.</p>
          </caption>
          <graphic xlink:href="1746-1596-6-51-10"/>
        </fig>
      </sec>
    </sec>
    <sec>
      <title>Discussion</title>
      <p>The adenocarcinoma in the present case was early microinvasive with width of 0.5 cm and depth of 0.3 cm. Histologically, the adenocarcinoma resembled endometrial endometrioid adenocarcinoma (grade 1), and negative for mucins. Therefore, the adenocarcinoma was EMEA [<xref ref-type="bibr" rid="B1">1</xref>]. The diagnosis of CIN 3 is apparent in the present case [<xref ref-type="bibr" rid="B1">1</xref>].</p>
      <p>Squamous cell carcinoma and adenocarcinoma can coexist in the uterine cervix [<xref ref-type="bibr" rid="B8">8</xref>-<xref ref-type="bibr" rid="B13">13</xref>]; there are several case reports of this in the English literature [<xref ref-type="bibr" rid="B8">8</xref>-<xref ref-type="bibr" rid="B13">13</xref>]. From the standpoint of CIN, Brown et al [<xref ref-type="bibr" rid="B2">2</xref>] reported that 16 cases of cervical glandular atypia and only 1 case adenocarcinoma in situ were found in 105 cases of CIN 3. From the standpoint of cervical adenocarcinoma, Maier and Norris [<xref ref-type="bibr" rid="B9">9</xref>] reported that 99 cases of CIN were detected in 230 cases of cervical adenocarcinoma. About half of such cases were CIN 2 or CIN 3 [<xref ref-type="bibr" rid="B9">9</xref>]. There is only one report that there is an association of adenocarcinoma in situ and cervical squamous cell carcinoma [<xref ref-type="bibr" rid="B10">10</xref>]. However, cases of simultaneous adenocarcinoma and CIN3 are very rare in the English literature [<xref ref-type="bibr" rid="B10">10</xref>,<xref ref-type="bibr" rid="B14">14</xref>-<xref ref-type="bibr" rid="B19">19</xref>]. In addition, cases of simultaneous early microinvasive adenocarcinoma and CIN3 are very rare [<xref ref-type="bibr" rid="B17">17</xref>,<xref ref-type="bibr" rid="B18">18</xref>]. Furthermore, cases of simultaneous endometrioid adenocarcinoima and CIN3 are extremely rare. Therefore, the present case of coexistence of EMEA and CIN3 appears extremely rare.</p>
      <p>In the present study, the cervical lesion is typical CIN3, HGSIL, or CIS. No invasion was recognized. The histological features fulfill the diagnosis of CIN 3 [<xref ref-type="bibr" rid="B1">1</xref>]. The adenocarcinoma element in the present study was of EMEA negative for mucins [<xref ref-type="bibr" rid="B1">1</xref>]. In both elements, adequate structural and cytological atypia regarded as malignant was recognized. The positive immunoreaction of p53 protein in the present EMEA and CIN3 strongly suggests that both lesions in the present study are malignant.</p>
      <p>There have been few immunohistochemical studies in simultaneous squamous neoplasm and adenocarcinoma in the uterine cervix [<xref ref-type="bibr" rid="B10">10</xref>]. The present study extensively examined the immunoprofile of EMEA and CIN3. The EMEA and CIN3 showed different immunoprofile, suggesting that they are different neoplasms. The CK profiling of EMEA showed predominant presence of low molecular weight cytokeratin, while CIN3 high-molecular weight cytokeratin. Since squamous lesions express high-molecular weight CK while adenocarcinoma low-molecular weight cytokeratin [<xref ref-type="bibr" rid="B20">20</xref>], the present data indicate the CIN3 is squamous lesions and EMEA is adenocarcinoma. The presence of p63 in CIN3 but not in EMEA indicates that CIN3 was squamous lesion and EMEA is not, since p63 is known to be expressed in squamous lesions but not in adenocarcinoma lesions [<xref ref-type="bibr" rid="B21">21</xref>]. Both components were negative for CK14, CK17, and CK20, suggesting that these three CKs are not expressed in either lesion. EMA was positive in CIN3, but negative in EMEA, suggesting that EMA is expressed only in CIN lesions. CA125 was strongly positive in EMA and mildly positive in CIN, suggesting that CA125 is mainly expressed in adenocarcinoma element rather than CIN. CA19-9 was mildly expressed in both EMEA and CIN3, suggesting that both lesions have a small amount of this carbohydrate antigen. p53 was positive in both components, suggesting that p53 gene is mutated in both components and that both components are malignant. Both components were strongly positive for ER, being compatible with the presence of ER of female genital organs. However, PgR was strongly positive for EMEA but negative in CIN3, suggesting the presence of PgR in EMEA, but not in CIN. Interestingly, MUC 1 was present in CIN3 but was absent in EMEA. MUC2, MUC5AC and MUC6 were negative in both components. MUC is mucin core protein gene product so that it was previously anticipated that MUCs are present in EMEA. These results indicate CIN3 may be positive for MUC1 and EMEA was negative for MUCs. Both elements were negative for chromogranin, synaptophysin, and CD56, indicating that both components do not show neuroendocrine features. Both components were negative for vimentin, desmin, and &#x3B1;-smooth mucle actin, indicating that these three mesenchymal antigens were absent in EMEA and CIN3. CEA was negative for both components, suggesting that EMEA may be negative for CEA. CD68 was negative in both components, indicating no histiocytic differentiation. Both components were negative for HER2/neu, suggesting that both components were negative for this receptor.</p>
      <p>In summary, the author presented a case of simultaneous EMEA and CIN3 of the uterine cervix in a 32-year-old Japanese woman with an emphasis on immunohistochemical findings.</p>
      <sec>
        <title>Consent</title>
        <p>Written informed consent was obtained from the patient for publication of this case report and accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.</p>
      </sec>
    </sec>
    <sec>
      <title>Competing interests</title>
      <p>The author declares that they have no competing interests.</p>
    </sec>
  </body>
  <back>
    <ref-list>
      <ref id="B1">
        <mixed-citation publication-type="book">
          <person-group person-group-type="editor">Tavassoli FA and Devilee</person-group>
          <article-title>World Health Organization Classification of Tumours. Pathology and genetics of tumours of the breast and female genital organs</article-title>
          <source>Tumours of uterine cervix</source>
          <year>2003</year>
          <publisher-name>IARC press, Lyon</publisher-name>
          <fpage>259</fpage>
          <lpage>311</lpage>
        </mixed-citation>
      </ref>
      <ref id="B2">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Brown</surname>
            <given-names>JL</given-names>
          </name>
          <name>
            <surname>Wells</surname>
            <given-names>M</given-names>
          </name>
          <article-title>Cervical glandular atypia associated with squamous intraepithelial neoplasm: a premalignant lesion?</article-title>
          <source>J Clin Pathol</source>
          <year>1986</year>
          <volume>39</volume>
          <fpage>22</fpage>
          <lpage>28</lpage>
          <pub-id pub-id-type="doi">10.1136/jcp.39.1.22</pub-id>
          <pub-id pub-id-type="pmid">3950029</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B3">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Terada</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Kawaguchi</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Furukawa</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Sekido</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Osamura</surname>
            <given-names>RY</given-names>
          </name>
          <article-title>Minute mixed ductal-endocrine carcinoma of the pancreas with predominant intraductal growth</article-title>
          <source>Pathol Int</source>
          <year>2002</year>
          <volume>52</volume>
          <fpage>740</fpage>
          <lpage>746</lpage>
          <pub-id pub-id-type="doi">10.1046/j.1440-1827.2002.01416.x</pub-id>
          <pub-id pub-id-type="pmid">12685552</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B4">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Terada</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Kawaguchi</surname>
            <given-names>M</given-names>
          </name>
          <article-title>Primary clear cell adenocarcinoma of the peritoneum</article-title>
          <source>Tohoku J Exp Med</source>
          <year>2005</year>
          <volume>206</volume>
          <fpage>271</fpage>
          <lpage>275</lpage>
          <pub-id pub-id-type="doi">10.1620/tjem.206.271</pub-id>
          <pub-id pub-id-type="pmid">15942157</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B5">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Terada</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Taniguchi</surname>
            <given-names>M</given-names>
          </name>
          <article-title>Intraductal oncocytic papillary neoplasm of the liver</article-title>
          <source>Pathol Int</source>
          <year>2004</year>
          <volume>54</volume>
          <fpage>116</fpage>
          <lpage>123</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1440-1827.2004.01594.x</pub-id>
          <pub-id pub-id-type="pmid">14720143</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B6">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Terada</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Moriki</surname>
            <given-names>T</given-names>
          </name>
          <article-title>Monolobar ductal plate malformation disease of the liver</article-title>
          <source>Pathol Int</source>
          <year>2010</year>
          <volume>60</volume>
          <fpage>407</fpage>
          <lpage>412</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1440-1827.2010.02535.x</pub-id>
          <pub-id pub-id-type="pmid">20518892</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B7">
        <mixed-citation publication-type="journal">
          <article-title>Terada TLarge cell neuroendocrine carcinoma with sarcomatous changes of the endometrium: a case report with immunohistochemical studies and molecular genetic study of KIT and PDGFRA</article-title>
          <source>Pathol Res Pract</source>
          <year>2010</year>
          <volume>206</volume>
          <fpage>420</fpage>
          <lpage>425</lpage>
          <pub-id pub-id-type="doi">10.1016/j.prp.2009.12.008</pub-id>
          <pub-id pub-id-type="pmid">20189318</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B8">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Choo</surname>
            <given-names>YC</given-names>
          </name>
          <name>
            <surname>Naylor</surname>
            <given-names>B</given-names>
          </name>
          <article-title>Coexistance of squamous cell carcinoma and adenocarcinoma of the uterine cervix</article-title>
          <source>Gynecol Oncol</source>
          <year>1984</year>
          <volume>17</volume>
          <fpage>168</fpage>
          <lpage>174</lpage>
          <pub-id pub-id-type="doi">10.1016/0090-8258(84)90073-8</pub-id>
          <pub-id pub-id-type="pmid">6706225</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B9">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Maier</surname>
            <given-names>RC</given-names>
          </name>
          <name>
            <surname>Norris</surname>
            <given-names>HJ</given-names>
          </name>
          <article-title>Coexistance of cervical intraepithelial neoplasm with primary adenocarcinoma of the endocervix</article-title>
          <source>Obstet Gynecol</source>
          <year>1980</year>
          <volume>56</volume>
          <fpage>361</fpage>
          <lpage>364</lpage>
          <pub-id pub-id-type="pmid">7422175</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B10">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Terada</surname>
            <given-names>T</given-names>
          </name>
          <article-title>Simultaneous squamous cell carcinoma in situ and adenocarcinoma in situ of the uterine cervix in a 36-year-old Japanese woman</article-title>
          <source>Arch Gynecol Obstet</source>
          <year>2010</year>
          <volume>281</volume>
          <fpage>527</fpage>
          <lpage>530</lpage>
          <pub-id pub-id-type="doi">10.1007/s00404-009-1208-8</pub-id>
          <pub-id pub-id-type="pmid">19693522</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B11">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Vasilijevic</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Stanimirovic</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Stanojevic</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Djukic</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Vasilijevic</surname>
            <given-names>N</given-names>
          </name>
          <article-title>Primary double invasive cervical carcinoma, squamous cell carcinoma and adenocarcinoma: case report</article-title>
          <source>Eur J Gynecol Oncol</source>
          <year>2008</year>
          <volume>29</volume>
          <fpage>411</fpage>
          <lpage>413</lpage>
        </mixed-citation>
      </ref>
      <ref id="B12">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Goto</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Takeuchi</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Yakihara</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Kosigi</surname>
            <given-names>F</given-names>
          </name>
          <article-title>Synchronous invasive squamous cell carcinoma and clear cell adenocarcinoma of the uterine cervix: a different human papillomavirus status</article-title>
          <source>Gynecol Oncol</source>
          <year>2005</year>
          <volume>97</volume>
          <fpage>976</fpage>
          <lpage>979</lpage>
          <pub-id pub-id-type="doi">10.1016/j.ygyno.2005.03.027</pub-id>
          <pub-id pub-id-type="pmid">15896829</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B13">
        <mixed-citation publication-type="journal">
          <name>
            <surname>van Aspert-van Erp</surname>
            <given-names>AJ</given-names>
          </name>
          <name>
            <surname>Smedts</surname>
            <given-names>FM</given-names>
          </name>
          <name>
            <surname>Vooijs</surname>
            <given-names>GP</given-names>
          </name>
          <article-title>Severe cervical glandular cell lesions with coexisting squamous cell lesions</article-title>
          <source>Cancer</source>
          <year>2004</year>
          <volume>25</volume>
          <fpage>218</fpage>
          <lpage>227</lpage>
        </mixed-citation>
      </ref>
      <ref id="B14">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Anastasiadis</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Koutlaki</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Tamiolakis</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Liberis</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>Galazios</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Sivridis</surname>
            <given-names>E</given-names>
          </name>
          <article-title>Invasive adenocarcinoma of mixed endocervical and clear cell types, associated with invasive squamous cell carcinoma of the cervix uteri: a case report</article-title>
          <source>Eur J Gynecol Obstet</source>
          <year>2000</year>
          <volume>21</volume>
          <fpage>173</fpage>
          <lpage>176</lpage>
        </mixed-citation>
      </ref>
      <ref id="B15">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Skopelitou</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Hadjiyannakis</surname>
            <given-names>M</given-names>
          </name>
          <article-title>Enteric type villoglandular papillary adenocarcinoma of the uterine cervix associated with in situ squamous cell carcinoma: case report and review of the literature</article-title>
          <source>Eur J Gynecol Obstet</source>
          <year>1996</year>
          <volume>17</volume>
          <fpage>309</fpage>
          <lpage>314</lpage>
        </mixed-citation>
      </ref>
      <ref id="B16">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Lauchian</surname>
            <given-names>SC</given-names>
          </name>
          <name>
            <surname>Penner</surname>
            <given-names>DW</given-names>
          </name>
          <article-title>Simultaneous adenocarcinoma in situ and epidermoid carcinoma in situ: report of two cases</article-title>
          <source>Cancer</source>
          <year>1967</year>
          <volume>20</volume>
          <fpage>2250</fpage>
          <lpage>2254</lpage>
          <pub-id pub-id-type="doi">10.1002/1097-0142(196712)20:12&lt;2250::AID-CNCR2820201228&gt;3.0.CO;2-B</pub-id>
          <pub-id pub-id-type="pmid">6073902</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B17">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Wolk</surname>
            <given-names>BM</given-names>
          </name>
          <name>
            <surname>Kime</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Albites</surname>
            <given-names>V</given-names>
          </name>
          <article-title>Simultaneous in situ squamous cell carcinoma and microinvasive adenocarcinoma of the cervix</article-title>
          <source>Int J Gynecol Obstet</source>
          <year>1981</year>
          <volume>19</volume>
          <fpage>69</fpage>
          <lpage>72</lpage>
          <pub-id pub-id-type="doi">10.1016/0020-7292(81)90041-2</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B18">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Yamasaki</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Ueda</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Sato</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Kobayashi</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Kurachi</surname>
            <given-names>K</given-names>
          </name>
          <article-title>Simultaneous squamous cell carcinoma in situ and early invasive adenocarcinoma of the uterine cervix</article-title>
          <source>Acta Obstet Gynecol Jpn</source>
          <year>1975</year>
          <volume>22</volume>
          <fpage>6</fpage>
          <lpage>9</lpage>
        </mixed-citation>
      </ref>
      <ref id="B19">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Toki</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Katayama</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Motoyama</surname>
            <given-names>T</given-names>
          </name>
          <article-title>Small cell neuroendocrine carcinoma of the uterine cervix associated with microinvasive squamous cell carcinoma and adenocarcinoma in situ</article-title>
          <source>Pathol Int</source>
          <year>1996</year>
          <volume>46</volume>
          <fpage>520</fpage>
          <lpage>525</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1440-1827.1996.tb03648.x</pub-id>
          <pub-id pub-id-type="pmid">8870009</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B20">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Smedts</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Ramaekers</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Troyanovsky</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Pruszczynski</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Link</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Lane</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Leich</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Schijf</surname>
            <given-names>C</given-names>
          </name>
          <article-title>Keratin expression in cervical cancer</article-title>
          <source>Am J Pathol</source>
          <year>1992</year>
          <volume>141</volume>
          <fpage>497</fpage>
          <lpage>511</lpage>
          <pub-id pub-id-type="pmid">1379783</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B21">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Owens</surname>
            <given-names>SR</given-names>
          </name>
          <name>
            <surname>Greenson</surname>
            <given-names>JK</given-names>
          </name>
          <article-title>Immunohistochemical staining for p63 is useful in the diagnosis of anal squamous cell carcinomas</article-title>
          <source>Am J Surg Pathol</source>
          <year>2007</year>
          <volume>31</volume>
          <fpage>285</fpage>
          <lpage>290</lpage>
          <pub-id pub-id-type="doi">10.1097/01.pas.0000213362.10756.d3</pub-id>
          <pub-id pub-id-type="pmid">17255774</pub-id>
        </mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
